Nestle Investor Event Presentation Deck
16
●
●
●
●
●
●
Boosting growth
in the core
Winning strategy
Market dynamics
Aging population
Prevalence of major diseases
Regulatory dynamics
Medical practice shifts
Regulatory
9 registration licenses
1st liquid Food for Special
Medical Purpose
November 29, 2022
1st cancer Food for Special
Medical Purpose
Building a leader in China
Invest in local pipeline
Local R&D
• Local manufacturing
•
First liquid Food for Special
Medical Purpose plant in
China
In market execution
Scaled medical sales team
Health Care Professional
education
Key Opinion Leader
collaboration
B
#1 in
pediatric
allergy
Noste
JL 8
ALFARE
******
BEKE
PENT
肽敏舒
ALTHERA
SEARC
Nestle
A
PURIORE
wwwww
100-1
Nestlé
混敏舒
ALFAMINO
SEYRE
BERTA
#1 in
pediatric
growth
Noste
小佳膳
NUTREN S
STAR
Nestle
Mökit
PEPTAMEN SO
ESPESSE
menrue
LAN
#1 choice
for cancer
patients
NES
速熠素
-oral-
PROVE
Nestlé investor
seminar 2022View entire presentation